Microphthalmia-Associated Transcription Factor (MITF): Multiplicity in Structure, Function, and Regulation  by Shibahara, Shigeki et al.
Microphthalmia-Associated Transcription Factor (MITF):
Multiplicity in Structure, Function, and Regulation
Shigeki Shibahara, Kazuhisa Takeda, Ken-ichi Yasumoto, Tetsuo Udono, Ken-ichi Watanabe, Hideo Saito, and
Kazuhiro Takahashi
Department of Molecular Biology and Applied Physiology, Tohoku University School of Medicine, Aoba-ku, Sendai, Miyagi, Japan
Microphthalmia-associated transcription factor
(MITF) regulates the differentiation and development
of melanocytes and retinal pigment epithelium and is
also responsible for pigment cell-speci®c transcrip-
tion of the melanogenesis enzyme genes. Hetero-
zygous mutations in the MITF gene cause auditory±
pigmentary syndromes. MITF consists of at least ®ve
isoforms, MITF-A, MITF-B, MITF-C, MITF-H, and
MITF-M, differing at their N-termini and expression
patterns. Here we show a remarkable similarity
between the N-terminal domain of MITF-A and
cytoplasmic retinoic acid-binding proteins. To date,
four isoform-speci®c ®rst exons have been identi®ed
in the MITF gene: exons 1A, 1H, 1B, and 1M in the
5¢ to 3¢ direction, each of which encodes the unique
N-terminus of a given isoform. The 5¢-¯anking
regions of these isoform-speci®c exons are termed A,
H, B, and M promoters, respectively. Among these
promoters, the M promoter has received particular
attention, because it is functional only in melano-
cyte-lineage cells and is upregulated by Wnt signal-
ing via the functional LEF-1-binding site. Moreover,
the M promoter is upregulated by other transcription
factors, PAX3, SOX10, and CREB. The activity and
degradation of MITF-M are regulated by extracellu-
lar signals via protein phosphorylation, such as c-Kit
signaling. Together, multiple signals appear to con-
verge on the M promoter as well as on MITF
proteins, leading to the proper regulation of MITF-
M in melanocytes and other MITF isoforms in many
cell types. Key words: melanocyte/retinal pigment epithe-
lium/retinoic acid/Wnt signaling/Waardenburg syndrome.
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M
ice with semidominant mutations at the micro-
phthalmia (Mitf) locus show some of the following
defects: loss of pigmentation, reduced eye size,
failure of secondary bone resorption, reduced
numbers of mast cells, and early onset of deafness
(Silvers, 1979). Thus, microphthalmia-associated transcription
factor (Mitf), encoded at the mouse Mitf locus, plays an essential
role in the development and/or survival of several cell lineages,
including melanocytes, retinal pigment epithelium (RPE), mast
cells, and osteoclasts. Mitf (Hodgkinson et al, 1993; Hughes et al,
1993) and its human counterpart MITF (Tachibana et al, 1994)
contain a basic helix-loop-helix-leucine zipper (bHLH-LZ)
structure, which is required for DNA binding and dimer formation.
The initially identi®ed Mitf, now known as melanocyte-speci®c
Mitf (Mitf-M), consists of 419 amino acid residues and shares 94.4%
identity with MITF-M (Tachibana et al, 1994). MITF-M mRNA is
exclusively expressed in melanocytes and pigmented melanoma
cells, but is not detectable in other cell types, including human
RPE cell lines (Amae et al, 1998; Fuse et al, 1999; Vachtenheim and
NovotnaÂ, 1999). In fact, MITF-M ef®ciently transactivates the
melanogenesis enzyme genes, such as tyrosinase and tyrosinase-related
protein 1 (TRP-1) in cultured cells (Yasumoto et al, 1994, 1997; for
review, Shibahara et al, 1998, 1999, 2000). Moreover, ectopic
expression of MITF-M converted NIH/3T3 ®broblasts into cells
expressing the tyrosinase and TRP-1 genes (Tachibana et al, 1996).
Together, these results indicate MITF-M as a key regulator for
melanocyte differentiation.
MITF consists of at least ®ve isoforms with distinct amino-
termini, MITF-A, MITF-B, MITF-C, MITF-H, and MITF-M
(Amae et al, 1998; Fuse et al, 1999; Udono et al, 2000) (Fig 1). The
N-terminus of MITF-M, domain M, consists of 11 amino acid
residues, and is encoded by the melanocyte-speci®c exon 1 (exon
1M) (Fuse et al, 1996). All isoforms with the extended amino-
termini share the entire carboxyl portion with MITF-M. The
unique N-terminus of MITF-A, MITF-B, MITF-C, or MITF-H is
followed by the common region of 83 amino acid residues (domain
B1b), which is signi®cantly similar to the equivalent portion of
TFEB (Amae et al, 1998) and TFE3 (Yasumoto et al, 1998; Rehli
et al, 1999). Moreover, domain C of MITF-C shares signi®cant
amino acid similarity with the putative transactivation segments of
the two leukemogenic factors, ENL and AF-9 (Fuse et al, 1999;
Shibahara et al, 2000).
Here we summarize the new ®ndings concerning the regulation
of MITF-M expression and discuss the function of MITF isoforms.
Comprehensive reviews on the general properties of MITF have
been published (Moore, 1995; Shibahara et al, 1998, 1999, 2000;
Yasumoto et al, 1998; Tachibana, 1999; Goding, 2000).
STRUCTURAL ORGANIZATION OF THE MITF GENE
The MITF gene consists of at least four promoters, their
consecutive ®rst exons (exons 1A, 1H, 1B, and 1M), and eight
downstream exons that are common to all isoforms (Udono et al,
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2000) (Fig 2). The structural organization of the MITF gene is
similar to that of the mouse Mitf gene (Hallsson et al, 2000). The N-
termini of the MITF isoforms are encoded by the separate ®rst
exons, although the ®rst exon encoding the N-terminus of MITF-
C has not been identi®ed. Among the ®rst exons identi®ed, exon
1B is unique because it is also used as a second exon (B1b exon),
when the primary transcripts, initiated from exon 1A, exon 1H, or
putative exon 1C, are subjected to splicing (Udono et al, 2000).
Exon 1B therefore encodes the 5¢-untranslated region of MITF-B
mRNA, the N-terminal domain of MITF-B (domain B1a), and
domain B1b (see Fig 1).
In contrast to MITF-M, other MITF isoforms are widely
expressed in many cell types (Amae et al, 1998; Fuse et al, 1999;
Udono et al, 2000). These expression pro®les of MITF isoform
mRNA suggest that each promoter/exon 1 is under separate
control. Especially, the M promoter, the 5¢-¯anking region of exon
1M, shows the melanocyte-speci®c promoter function (Fuse et al,
1996; Udono et al, 2000). In fact, MITF-M protein was detected in
all of 76 melanoma surgical specimens examined (King et al, 1999).
Together, MITF-M has been established as a speci®c marker for
melanocyte-lineage cells.
Consistent in part with the ubiquitous expression patterns of
MITF-A and MITF-H, the A and H promoters lack a typical
TATA-box at the usual position (Udono et al, 2000), which is
commonly seen in many house-keeping genes. Transient expres-
sion assays suggest that the A and H promoters are functional in
RPE, melanoma, and cervical cancer cell lines, but no noticeable B
promoter activity was detected in these cell lines (Udono et al,
2000). It is of interest to study whether each alternative promoter of
the MITF gene functions independently or whether some of these
alternative promoters are transcribed in a mutually exclusive
manner.
LESSONS FROM BLACK-EYED WHITE AND RED-EYED
WHITE MITF MUTANTS
We are interested in the two recessive Mitf mutant mice, black-
eyed white Mitfmi±bw and red-eyed white Mitfmi±rw, because the
former may represent the phenotype of Mitf-M de®cient mice and
the latter may mimic the phenotype of mice lacking all Mitf
isoforms with extended N-termini. Essential requirement of Mitf-
M for melanocyte development was veri®ed by the molecular
lesion of Mitfmi±bw mice (Yajima et al, 1999), which are character-
ized by the complete white coat color, deafness, and normally
pigmented RPE without any ocular abnormalities. In Mitfmi±bw
mice, the insertion of an L1 retrotransposable element in the intron
3 between exon 3 and exon 4 leads to complete repression of Mitf-
M mRNA expression and to reduction of Mitf-A and Mitf-H
mRNA expression (Yajima et al, 1999). In this context, the M
promoter represents the most downstream promoter of the MITF/
Mitf gene (Tassabehji et al, 1994; Fuse et al, 1996; Hallsson et al,
2000; Udono et al, 2000), and may be most susceptible to the
transcriptional repression caused by the insertion of the L1 element
(Fig 2). These results indicate that MITF-M/Mitf-M is a key
regulator of the melanocyte development but is dispensable for
RPE development. Indeed, in situ hybridization analysis revealed
that Mitf isoform mRNA containing the B1b exon are expressed in
the outer layer of the optic cup, the prospective RPE (Amae et al,
1998). These results indicate that MITF isoforms with extended N-
termini, such as MITF-A or MITF-H, are important for RPE
differentiation.
The homozygous Mitfmi±rw mice exhibit small red eyes and a
white coat with some pigmented spots around the head and/or tail
(SteingrõÂmsson et al, 1994), and its molecular defect is a deletion of
the genomic DNA segment containing exon 1H and exon 1B
(Hallsson et al, 2000) (Fig 2). Thus, Mitfmi±rw mice completely lack
Mitf-H and Mitf-B but may express aberrant Mitf-A lacking
domain B1b, encoded by the 3¢-portion of exon 1B; however,
deletion of B1b exon results in a frame shift in such aberrant
mRNA species. It is therefore conceivable that the phenotype of
Mitfmi±rw mice represents the loss of function of all Mitf isoforms
containing domain B1b. Moreover, these mutant mice are de®cient
in melanocytes possibly due to the loss of Mitf-M expression,
except for melanocytes located in the head and tail regions,
suggesting that the deleted genomic DNA segment may contain the
enhancer for the M promoter.
In summary, Mitf-M is essential for melanocyte differentiation,
whereas other Mitf isoforms with extended N-termini are respon-
sible for differentiation of RPE and development of normal eye.
Transcription from the M promoter is in¯uenced not only by the
proximal promoter region but also by the upstream and down-
stream cis-regulatory elements (Fig 2), suggesting the existence of
the complex regulatory network of transcription factors.
A LINK BETWEEN MITF AND RETINOID METABOLISM
MITF-A is a predominant isoform expressed in a human RPE line
of fetal origin and is also expressed in many cell types (Amae et al,
1998; Fuse et al, 1999; Udono et al, 2000). Domain A of MITF-A
shares signi®cant amino acid identity with the N-terminus of TFE3
(Yasumoto et al, 1998; Rehli et al, 1999). Here we show a similarity
between domain A of MITF-A and cytoplasmic retinoic acid-
binding protein (CRABP) (Fig 3). Two types of CRABP,
CRABP-I and CRABP-II, have been extensively characterized
but their functions are less well understood (reviewed by Li and
Norris, 1996). CRABP-I is expressed in many tissues, whereas
CRABP-II expression is localized to the skin. It should be noted
that three consecutive portions, covering the entire domain A, are
aligned to the equivalent portions of CRABP. Especially, the
middle portion of domain A (12 amino acid residues) is remarkably
similar to CRABP but is less conserved in TFE3. The implication
of such similarity remains unknown, but is reminiscent of the
phenotype of a recessive Mitf mutant, Mitfvitiligo (Mitfvit) (Lerner et al,
1986; SteingrõÂmsson et al, 1994), which shows late-onset retinal
degeneration and abnormalities in retinoid metabolism (Smith et al,
1994). When young, the homozygous Mitfvit mice appear normal,
with uniformly lighter color, but show aging-dependent melano-
cyte loss (Lerner et al, 1986). In addition, plucking hairs promotes
the regrowth of amelanotic hairs due to melanocyte loss in the
plucked areas, indicating a crucial role of Mitf-M in postnatal
maintenance of follicular melanocytes. The molecular lesion of
Mitf-Mvit is the Asp222Asn substitution in the helix 1 of the bHLH-
LZ domain (SteingrõÂmsson et al, 1994). The Mitf-Mvit protein was
shown to bind in vitro to DNA as either a homodimer or a
heterodimer (Hemesath et al, 1994). It is therefore conceivable that
the Asp to Asn substitution in the helix 1 of MITF-M, MITF-A, or
other MITF isoforms may impair the interaction with a hitherto
unidenti®ed protein.
Figure 1. Structures of the MITF isoforms. Shown are the
schematic representation of MITF-M and other isoforms, including
MITF-A, MITF-B, MITF-C, and MITF-H. All MITF isoforms differ at
their N-termini but share the entire carboxyl portion. Domain B1a and
domain B1b of MITF-B are encoded by exon 1B (see Fig 2). The
transcriptional activation domain (AE) (Sato et al, 1997), the bHLH-LZ
structure, and the serine-rich region (Ser) are indicated. The exons are
indicated by horizontal columns (closed or open) above the domains.
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MODULATION OF MITF-M'S FUNCTION BY
PHOSPHORYLATION
Recent studies have established that function and stability of
MITF-M are regulated by phosphorylation, as summarized in
Fig 4. The c-Kit gene is one of the targets for MITF-M (Tsujimura
et al, 1996), and the Steel/c-Kit signaling triggers rapid phosphoryl-
ation of MITF-M via MAP kinase at Ser 73 (Hemesath et al, 1998).
The phosphorylation of MITF-M at Ser 73 results in upregulation
of the MITF-M function. In this process, CBP/p300 transcription
coactivator interacts with MITF-M, further activating the function
of MITF-M (Sato et al, 1997; Price et al, 1998). Moreover, c-Kit
signaling was shown to phosphorylate MITF-M at Ser 409 via p90
Rsk, a member of the serine/threonine kinases (Wu et al, 2000).
These c-Kit-induced phosphorylations caused short-lived acti-
vation and destruction of MITF-M. In this context, ubiquitin-
conjugating enzyme hUBC9 has been identi®ed as a potential
interacting partner for MITF-M (Xu et al, 2000). It was shown that
phosphorylation of MITF-M at Ser 73 is a prerequisite to the
hUBC9-mediated degradation of MITF-M. Moreover, Takeda
et al (2000a) reported that the Ser298 is phosphorylated by glycogen
synthase kinase 3b (GSK3b), thereby enhancing the function of
MITF-M. In fact, a Ser298P substitution was found to be associated
with WS2 (Tassabehji et al, 1995); however, a signal targeting
GSK3b, leading to activation of MITF-M, remains to be deter-
mined, although GSK3b is known as a negative regulator of the
Wnt signaling pathway (reviewed by Eastman and Grosschedl,
1999). It is noteworthy that the phosphorylation sites that have
been characterized to date are common to all MITF isoforms.
MITF-M PROMOTER AS A TARGET OF WNT
SIGNALING
Recent studies from other investigators (Dorsky et al, 2000) and our
group (Takeda et al, 2000b) have demonstrated that Wnt signaling
upregulates MITF-M expression. Wnt proteins, secreted cysteine-
rich glycoproteins, have been established as developmentally
important signaling molecules (reviewed by Cadigan and Nusse,
1997). Wnt-1 and Wnt-3a are especially important in the
expansion of neural crest precursors and in determining the fates
of neural crest cells (Dorsky et al, 1998). Targeted disruption of the
Wnt-1 and Wnt-3 genes in the mouse causes de®ciency of neural
crest derivatives, including melanocytes (Ikeya et al, 1997).
Moreover, the onset of Wnt-3a expression is detected at 7.5
embryonic days (Takada et al, 1994), which precedes the onset of
Mitf expression in neural crest cells (9.5±10.5 embryonic days)
Figure 2. Structural organization of the MITF gene. The direction
of transcription is from left to right, indicated by arrows. The 5¢ and 3¢-
untranslated exons are indicated by open boxes, and the protein-coding
exons are indicated by closed boxes. The numbers show exons. Domains
A, C, and H are encoded by exon 1A, putative exon 1C, and exon 1H,
respectively. Note that exon 1C remains to be determined. The 3¢-
portion of exon 1B (exon B1b) is used as a second exon for generation
of MITF-A, MITF-C, and MITF-H mRNA. The M promoter region is
highlighted to show multiple cis-acting elements, which are bound by
the indicated transcription factors. Exons 2±9 are common to all
isoforms. Also indicated are the equivalent positions of the deletion
identi®ed in red-eyed white Mitfmi±rw mice (Hallsson et al, 2000) and the
insertion seen in black-eyed white Mitfmi±bw mice (Yajima et al, 1999).
Figure 3. Sequence alignment of CRABP
and the N-terminus of MITF-A. Domain A
and the N-terminal portion of human TFE3 are
aligned to human CRABP-1 and CRABP-II.
Gaps (±) are introduced to obtain better
alignment. Residues of CRABP within 3.5 AÊ of
bound ligand are indicated (+) (Li and Norris,
1996). The positions of aligned regions are
schematically shown as stippled boxes at the
bottom. The entire structure of CRABP is shown
over the N-termini of MITF-A and TFE3.
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(Nakayama et al, 1998). These results suggest that Wnt-3a is a good
candidate that may regulate the differentiation of neural crest cells
toward melanocytes.
The signals evoked by Wnt proteins lead to intracellular
accumulation of b-catenin, a key downstream component of the
Wnt signaling pathway (reviewed by Cadigan and Nusse, 1997;
Eastman and Grosschedl, 1999). b-Catenin then activates the target
genes through the interaction with a member of LEF-1/TCF
transcription factors, containing a high-mobility group domain.
Thus, LEF-1/TCF transcription factors mediate a nuclear response
to Wnt signals. We have shown that exogenously added Wnt-3a
protein induces endogenous Mitf-M mRNA in cultured melano-
cytes (Takeda et al, 2000b). In addition, we identi®ed the functional
LEF-1-binding site in the M promoter (see Fig 2), and provided
evidence that Wnt-3a signaling recruits b-catenin and LEF-1 to the
M promoter, leading to the increased transcription from the M
promoter. These results indicate a direct link between Wnt
signaling and Mitf-M/MITF-M expression; however, the effect of
Wnt-3a signaling observed may mimic that of other Wnt
molecules. Further studies, such as extensive in situ hybridization
analysis and gene knock-out experiments, will be required to reveal
the bona ®da Wnt gene, which regulates the expression of Mitf-M
mRNA in vivo.
REGULATION OF MITF-M PROMOTER BY MULTIPLE
TRANSCRIPTION FACTORS
The M promoter is upregulated via the separate cis-acting elements
by CREB (Bertolotto et al, 1998; Price et al, 1998), PAX3
(Watanabe et al, 1998), and SOX10 (Bondurand et al, 2000; Lee
et al, 2000; Potterf et al, 2000; Verastegui et al, 2000) (see Fig 2).
CREB is phosphorylated and functionally activated via cAMP in
response to MSH signaling (Fig 4), suggesting an important role of
MITF-M in sun tanning (reviewed by BuscaÁ and Ballotti, 2000).
Both PAX3 and SOX10 are directly involved in the pathogenesis
of auditory-pigmentary disorders. PAX3 is a transcription factor
with a paired-homeodomain, and is responsible for Waardenburg
syndrome (WS) type 1 and 3 (Tassabehji et al, 1995). SOX10 is a
new member of the SOX family transcription factors with a high-
mobility group box as a DNA-binding motif (Pusch et al, 1998). A
truncation mutation of the Sox10 gene is associated with the mouse
mutant Dominant megacolon, a model for human congenital
megacolon (Hirschsprung disease) (Southard-Smith et al, 1998).
SOX10 is defective in some cases of Shah±Waardenburg syndrome,
also known as Waardenburg-Hirschsprung disease or WS4, which
is characterized by aganglionic megacolon, sensorineural deafness,
and pigmentation abnormalities (Pingault et al, 1998). Thus,
SOX10 is responsible for differentiation of the two types of neural
crest-derived cells, melanocytes and intestinal ganglia cells.
Moreover, a single heterozygous mutation of SOX10 was found
in a patient affected with a mild form of the Yemenite deaf±blind
hypopigmentation syndrome (Bondurand et al, 1999). It is therefore
conceivable that PAX3 and SOX10 may affect the development of
melanocytes by regulating transcription of the M promoter.
Recently, by in situ hybridization analysis we showed coexpres-
sion of Sox10 and Mitf (most likely Mitf-M) mRNA in migrating
melanoblasts at mouse embryonic day (E) 11.5 (Watanabe et al,
2000). By E 13.5, Sox10 mRNA expression became undetectable
in migrating melanoblasts, in which Mitf expression, however,
continues to be detectable. In this context, Mitf-positive cells were
undetectable in the homozygous Dominant megacolon embryos of E
12.5 (Bondurand et al, 2000). In postnatal day 8 and adult cochleas,
Sox10 expression was detected only in the supporting cells of the
organ of Corti (Watanabe et al, 2000). Taken together, these results
support the notion that Sox10 is required for transcription from the
M promoter of the MITF/Mitf gene during early stage of
melanoblast development.
MOLECULAR BASES OF WAARDENBURG SYNDROME
TYPE 2 AND TIETZ SYNDROME
Mutations in the MITF gene have been identi®ed in some patients
with WS2, a typical auditory±pigmentary syndrome (Farrer et al,
1994; Tassabehji et al, 1994, 1995; Nobukuni et al, 1996). It is
Figure 4. Regulation of MITF-M by multiple
signals. Extracellular signaling molecules and their
receptors are shown. Three phosphorylation sites
indicated are the Ser residues at 73, 298, and 409.
Interacting proteins, CBP/p300 and hUBC9, are
also indicated. Also shown is the threonine-rich
domain (T), which possesses modest
transcriptional activation activity (Takeda et al,
2000a). A signal targeting GSK3b, leading to
activation of MITF-M, remains to be determined.
c-Kit triggers dual phosphorylations at Ser73 via
MAPK and Ser409 via Rsk, leading to activation
and degradation of MITF-M, respectively (Wu et
al, 2000).
Figure 5. MITF mutations associated with
WS2 or Tietz syndrome. The mutations found
in individuals affected with WS2 syndrome
(Tassabehji et al, 1994, 1995; Nobukuni et al,
1996) are shown above the functional domains.
The del R217 is responsible for Tietz syndrome
(Amiel et al, 1998). Asterisks and triangles indicate
the splicing mutations and the nonsense
mutations, respectively. The S298P substitution
and the del R217 are enlarged.
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noteworthy that the missense mutations are clustered in the bHLH-
LZ structure, which is required for DNA-binding and dimer
formation, except for the Ser298P substitution (Fig 5). WS2 is an
autosomal dominant disorder characterized by varying combin-
ations of sensorineural hearing loss, heterochromia iridis, and
patchy abnormal pigmentation of the hair and skin (reviewed by
Liu et al, 1995). The exhibited hypopigmentation and hearing
impairment are caused by the lack of melanocytes in skin and inner
ears. The identi®ed MITF mutations include splicing mutations,
nonsense mutations, and missense mutations (Fig 5), but there is
no particular correlation between the molecular defects of mutant
MITF proteins and clinical severity. These results support the
notion that haploinsuf®ciency of MITF-M is a molecular basis for
WS2 (Nobukuni et al, 1996). On the other hand, most of the MITF
mutations may also affect the functions of MITF isoforms with
extended N-termini, such as MITF-A and MITF-H, although
phenotypic consequences of altered function of MITF-A and other
isoforms are not apparent in WS2. It is therefore conceivable that
melanocytes are most sensitive to the reduced levels of functional
MITF and that altered functions of MITF isoforms may be
phenotypically detectable only in the homozygous state (reviewed
by Shibahara et al, 1999), as seen in the homozygous Mitfmi±rw mice.
Recently, a mutation responsible for Tietz syndrome (albinism±
deafness syndrome) was identi®ed as an in-frame deletion of the
MITF gene, removing one of four consecutive Arg residues (del
R217) in the basic region of MITF-M (Amiel et al, 1998) (Fig 5).
Tietz syndrome is characterized by profound deafness, generalized
albinism with blue eyes, and hypoplasia of the eyebrows (Tietz,
1963). Unlike WS2, Tietz syndrome shows dominant inheritance
with complete penetrance and does not involve the eyes. In
contrast to Tietz syndrome, patchy depigmentation is characteristic
of WS2, and deafness is seen in 77% of WS2 individuals (Liu et al,
1995). Thus, the del R217 mutation causes more severe
dysfunction of melanocytes than do other MITF mutations. It is
unknown whether melanocytes are present in the skin of patients
affected with Tietz syndrome.
Surprisingly, the del R217 mutation found in Tietz syndrome is
equivalent to the mouse semidominant microphthalmia (mi) mutation
(Hodgkinson et al, 1993). The heterozygote mi mice show white
spotting of the coat and reduced pigment in the iris, and the
homozygotes present with totally white, deaf, small eyes, and
osteopetrosis. The functional consequence of the del R217
mutation was shown to be a loss of DNA-binding activity and to
function as a dominant negative form of MITF-M (Hemesath et al,
1994). Moreover, MITF-M protein, containing the del R217, is
unable to translocate to the nucleus and inhibits nuclear localization
of wild-type MITF-M (Takebayashi et al, 1996). These results
together with the phenotypic differences between Tietz syndrome
and WS2 suggest that a dominant-negative function of the del-
R217 MITF-M is responsible for Tietz syndrome.
PROSPECTS
The MITF gene consists of widely spaced multiple promoters,
which generate not only the diversity in the transcriptional
regulation of these promoters but also the structurally different
isoforms. The MITF gene will be a good model to study the
mechanism of promoter selectivity during development or under
certain metabolic conditions, perhaps related to retinoid metabol-
ism. The isoform multiplicity of MITF also provides the functional
diversity and redundancy. Future analysis of MITF isoforms in vivo
will clarify the role of each MITF isoform in differentiation and
development of the pigment cell and other cell types. It is also of
signi®cance to identify the interacting partners with the unique N-
terminal domains as well as the bHLH-LZ domain that modulates
the function of MITF isoforms.
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